Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ionescu

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
NIDA Research Monograph|January 1, 1978
An assessment of parameters in QuaSAR studies of narcotic analgesics and antagonistsR Katz, S Osborne, F Ionescu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 13, 2023
Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)Carol Jamieson, Carla M Canuso, Dawn F Ionescu, et al.
Acta Neuropsychiatrica|January 21, 2015
Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalographyDawn F Ionescu, Allison C Nugent, David A Luckenbaugh, et al.
Journal of Affective Disorders|April 29, 2014
Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attemptElizabeth D Ballard, Dawn F Ionescu, Jennifer L Vande Voort, et al.
Journal of Clinical Psychopharmacology|August 19, 2021
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or BehaviorCarla M Canuso, Dawn F Ionescu, Xiang Li, et al.
Journal of Affective Disorders|April 1, 2014
Do the dissociative side effects of ketamine mediate its antidepressant effects?David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, et al.
The Journal of Clinical Psychiatry|May 16, 2020
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)Dong-Jing Fu, Dawn F Ionescu, Xiang Li, et al.
The International Journal of Neuropsychopharmacology|August 30, 2020
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)Dawn F Ionescu, Dong-Jing Fu, Xin Qiu, et al.
Depression and Anxiety|December 20, 2013
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressantsMark J Niciu, Daniel C Mathews, Allison C Nugent, et al.
Psychiatry Research|April 20, 2013
An examination of associations between the inability to taste phenylthiocarbamide (PTC) and clinical characteristics and trait markers in first-episode, nonaffective psychotic disordersMichael T Compton, Dawn F Ionescu, Beth Broussard, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
NIDA Research Monograph|January 1, 1978
An assessment of parameters in QuaSAR studies of narcotic analgesics and antagonistsR Katz, S Osborne, F Ionescu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 13, 2023
Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)Carol Jamieson, Carla M Canuso, Dawn F Ionescu, et al.
Acta Neuropsychiatrica|January 21, 2015
Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalographyDawn F Ionescu, Allison C Nugent, David A Luckenbaugh, et al.
Journal of Affective Disorders|April 29, 2014
Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attemptElizabeth D Ballard, Dawn F Ionescu, Jennifer L Vande Voort, et al.
Journal of Clinical Psychopharmacology|August 19, 2021
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or BehaviorCarla M Canuso, Dawn F Ionescu, Xiang Li, et al.
Journal of Affective Disorders|April 1, 2014
Do the dissociative side effects of ketamine mediate its antidepressant effects?David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, et al.
The Journal of Clinical Psychiatry|May 16, 2020
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)Dong-Jing Fu, Dawn F Ionescu, Xiang Li, et al.
The International Journal of Neuropsychopharmacology|August 30, 2020
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)Dawn F Ionescu, Dong-Jing Fu, Xin Qiu, et al.
Depression and Anxiety|December 20, 2013
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressantsMark J Niciu, Daniel C Mathews, Allison C Nugent, et al.
Psychiatry Research|April 20, 2013
An examination of associations between the inability to taste phenylthiocarbamide (PTC) and clinical characteristics and trait markers in first-episode, nonaffective psychotic disordersMichael T Compton, Dawn F Ionescu, Beth Broussard, et al.
Pageof 8